Application of Quality Risk Management to Non-Production Processes in the Pharmaceutical Quality System

Bethesda, MD
Ask a Question
Duration: 1 day
Time: 8:30 a.m. - 4:00 p.m.

Since the publication of ICH Q9, Quality Risk Management, in 2005, there has been much written about its application to the production process, to product development, and to validation. Relatively little has been published about its application to some of the production supporting processes that are an important part of the pharmaceutical quality system. Annex 2 of ICH Q9 discusses the application of quality risk management to some of these supporting processes: change management/change control, quality defects, auditing/inspection, documentation, training, calibration/preventive maintenance and periodic review. In this course, we will present models of various supporting processes that integrate quality risk management into their design. This use of quality risk management should result in more effective and more efficient processes.

The real benefits from quality risk management arise when it is embedded in all processes, routine activities and the culture of the company. It is a way of thinking. We start toward achieving this goal by redesigning our processes and their accompanying procedures to contain risk analysis as a formal and integral part of the process. In the analysis of risk, we will consider severity, the consequences if a failure occurs, and the probability of failure.

Another neglected aspect of quality risk management that will be discussed briefly in the course is biases/errors made in the estimation of severity and especially the probability of a failure. The course will focus on how to recognize these biases and on how to reduce their influence so that more accurate estimations of severity and probability are obtained. Thus, better decisions can be made.

Who Should Attend

Quality and production managers will benefit from taking this course.

Prerequisites

Students should read ICH Q9 before the course.

More information coming soon.

Day 1

Upon completion of this course, you will be able to:

  • Design more effective and efficient non-production processes in which risk management is embedded
  • Apply risk management to change control; failures, deviations and CAPA; audits; documentation; training; preventive maintenance; and management review
Agenda is subject to change.

PLEASE READ  PDA is not affiliated or contracted with any outside hotel contracting company. If someone other than PDA or the PDA chosen hotel contacts you suggesting that they represent any PDA event, they do not. It is PDA's recommendation that you book your hotel directly through the official PDA chosen hotel that is listed on our web site.

PDA Training and Research Institute

4350 East West Highway
Bethesda, MD ,

Robert Kieffer, PhD, RGK Consulting

Dr. Kieffer is a recognized authority on quality management and on quality system design, with over 40 years experience in the pharmaceutical and medical device, industries.  He combines broad-based business, scientific and technical knowledge with skill as a teacher, facilitator and problem-solver. He has worked in over 50 countries.

Dr. Kieffer is a past president of the PDA, worked for Sterling Winthrop Inc. for 19 years and, since 1994, has been president of his own consulting business. He has numerous publications and presentations to his credit.